Structure Therapeutics, Inc. (GPCR)
21.87
-0.07
(-0.32%)
USD |
NASDAQ |
Oct 30, 16:00
22.41
+0.54
(+2.47%)
After-Hours: 20:00
Structure Therapeutics Price to Book Value : 1.150 for Oct. 30, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 30, 2026 | 1.150 |
| October 29, 2026 | 1.154 |
| October 28, 2026 | 1.129 |
| October 27, 2026 | 1.133 |
| October 26, 2026 | 1.110 |
| October 23, 2026 | 1.114 |
| October 22, 2026 | 1.153 |
| October 21, 2026 | 1.157 |
| October 20, 2026 | 1.203 |
| October 19, 2026 | 1.157 |
| October 16, 2026 | 1.108 |
| October 15, 2026 | 1.167 |
| October 14, 2026 | 1.150 |
| October 13, 2026 | 1.173 |
| October 12, 2026 | 1.257 |
| October 09, 2026 | 1.343 |
| October 08, 2026 | 1.350 |
| October 07, 2026 | 1.403 |
| October 06, 2026 | 1.444 |
| October 05, 2026 | 1.451 |
| October 02, 2026 | 1.455 |
| October 01, 2026 | 1.524 |
| September 30, 2026 | 1.644 |
| September 29, 2026 | 1.719 |
| September 28, 2026 | 1.844 |
| Date | Value |
|---|---|
| September 25, 2026 | 1.889 |
| September 24, 2026 | 1.894 |
| September 23, 2026 | 1.890 |
| September 22, 2026 | 1.941 |
| September 21, 2026 | 1.936 |
| September 18, 2026 | 1.840 |
| September 17, 2026 | 1.846 |
| September 16, 2026 | 1.867 |
| September 15, 2026 | 2.048 |
| September 14, 2026 | 2.021 |
| September 11, 2026 | 2.033 |
| September 10, 2026 | 2.080 |
| September 09, 2026 | 2.168 |
| September 08, 2026 | 2.123 |
| September 04, 2026 | 2.489 |
| September 03, 2026 | 2.489 |
| September 02, 2026 | 2.513 |
| September 01, 2026 | 2.478 |
| August 31, 2026 | 2.414 |
| August 28, 2026 | 2.491 |
| August 27, 2026 | 2.588 |
| August 26, 2026 | 2.595 |
| August 25, 2026 | 2.625 |
| August 24, 2026 | 2.577 |
| August 21, 2026 | 2.581 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Eli Lilly & Co. | 33.13 |
| Novo Nordisk A/S | 5.225 |
| Pfizer Inc. | 2.042 |
| Viking Therapeutics, Inc. | 5.910 |
| Liquidia Corp. | 20.58 |
Price to Book Value Related Metrics
| Price | 21.87 |
| Earnings Yield | -14.08% |
| Market Cap | 1.558B |